CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRVO CervoMed

交易中 11-15 11:15:01 EST

10.80

-0.12

-1.10%

最高11.29	最低10.46	成交量2.46万
今开10.99	昨收10.92	日振幅7.56%
总市值8,914万	流通市值4,203万	总股本825.37万
成交额26.50万	换手率0.63%	流通股本389.14万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRVO","market":"US","secType":"STK","nameCN":"CervoMed","latestPrice":10.8,"timestamp":1731687297362,"preClose":10.92,"halted":0,"volume":24620,"delay":0,"floatShares":3891401,"shares":8253741,"eps":-1.600656,"marketStatus":"交易中","marketStatusCode":2,"change":-0.12,"latestTime":"11-15 11:15:01 EST","open":10.99,"high":11.2852,"low":10.46,"amount":265006.34399,"amplitude":0.075568,"askPrice":10.94,"askSize":200,"bidPrice":10.8,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.600656,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731704400000},"adr":0,"adjPreClose":10.92,"postHourTrading":{"tag":"盘后","latestPrice":10.92,"preClose":10.92,"latestTime":"19:43 EST","volume":865,"amount":9445.32,"timestamp":1731631411784},"volumeRatio":0.959387},"requestUrl":"/m/hq/s/CRVO","defaultTab":"news","newsList":[{"id":"2483854558","title":"Cervomed Inc.盘中异动 下午盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483854558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483854558?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:02","pubTimestamp":1731528169,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时02分，Cervomed Inc.股票出现异动，股价快速下挫5.00%。截至发稿，该股报11.24美元/股，成交量8.0306万股，换手率0.97%，振幅8.96%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为672.15%、560.18%、168.40%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为140.00%、86.83%、73.71%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114040249a234f425&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114040249a234f425&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2482702939","title":"CervoMed 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482702939","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482702939?lang=zh_cn&edition=full","pubTime":"2024-11-12 21:38","pubTimestamp":1731418736,"startTime":"0","endTime":"0","summary":"   * CervoMed Inc   报告，截至9月30日的季度调整后每股亏损55美分，高于去年同期的每股-70美分。五位分析师对该季度的平均预期是每股亏损 41 美分。华尔街预期为每股-50美分至-31美分。* CervoMed 公司公布的本季度每股收益为亏损 55 美分。* 该公司当季亏损 475 万美元。* CervoMed Inc本季度股价下跌了16.8%，今年迄今为止上涨了59.1%。华尔街对 CervoMed 公司 12 个月目标价的中位数为 63.00  本摘要由 LSEG 11 月 12 日 01:38 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CervoMed 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2482544717","title":"Cervomed Inc.盘中异动 快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482544717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482544717?lang=zh_cn&edition=full","pubTime":"2024-11-12 03:12","pubTimestamp":1731352335,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日03时12分，Cervomed Inc.股票出现异动，股价急速跳水5.10%。截至发稿，该股报11.90美元/股，成交量6.5571万股，换手率0.79%，振幅6.86%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Cero Therapeutics Holdings, Inc.、Geovax Labs, Inc.、Aligos Therapeutics, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为790.86%、505.97%、262.47%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为132.14%、72.42%、65.93%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112031215a22d6161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112031215a22d6161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2482148437","title":"CervoMed Inc  预计每股亏损 41 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482148437","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482148437?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:45","pubTimestamp":1731084311,"startTime":"0","endTime":"0","summary":"CervoMed Inc  预计每股亏损 41 美分 - 财报前瞻CervoMed Inc CRVO.OQ CRVO.O预计将在11月11日公布截至2024年9月30日的业绩报告(估计)，季度收入将有所增长。LSEG分析师对CervoMed公司的平均预期是每股亏损41美分。华尔街对 CervoMed Inc 的 12 个月目标价中位数为 63.00 美元，高于其最新收盘价 12.53 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF25K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"gpt_icon":0},{"id":"2480407584","title":"Cervomed Inc.盘中异动 股价大涨5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480407584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480407584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730743,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分，Cervomed Inc.股票出现波动，股价快速上涨5.92%。截至发稿，该股报13.57美元/股，成交量2198股，换手率0.03%，振幅6.85%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为234.93%、128.40%、42.86%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.，振幅分别为29.83%、22.67%、12.78%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422322398e40472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422322398e40472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2480083599","title":"实时市场-脑力劳动正在进行，但神经药物开发人员仍需努力","url":"https://stock-news.laohu8.com/highlight/detail?id=2480083599","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480083599?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:38","pubTimestamp":1730475534,"startTime":"0","endTime":"0","summary":"您可以通过以下网址与我们分享您的想法  脑力劳动正在进行，但神经药物开发商仍有很长的路要走Canaccord Genuity分析师周五表示，神经系统疾病方面的需求尚未得到满足，这激起了人们对正在开发的治疗抑郁症、阿尔茨海默病和痴呆症等神经系统疾病药物试验数据的期待，这些疾病影响着全球数百万患者。嘉能可补充说，尽管在理解阿尔茨海默氏症这种神经退行性疾病方面还存在挑战，但 Leqembi 和 Kisunla 的成功已经到来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","IE00BJJMRZ35.SGD","IE00B42XCP33.USD","BK4532","DJX","LU0943347566.SGD","IE00B19Z9Z06.USD","SQQQ","LU0097036916.USD","LU0320765646.SGD","LU0203201768.USD",".SPX","QLD","IE0034235303.USD","MNQmain","LU0354030511.USD","LU0417517546.SGD","DXD","DOG","LU0096364046.USD",".DJI","IE00B2B36J28.USD","UDOW","BK4581","BMY",".IXIC","BK4504","LU0094547139.USD","JNJ","LU1064131342.USD","CRVO","DDM","NQmain","IE00BFTCPJ56.SGD","NMRA","PSQ","LU0795875086.SGD","QID","SDOW","TQQQ","LU0456855351.SGD","BK4139","LU1066051225.USD","BIIB","LU0061475181.USD","LU0203347892.USD","LU0708995401.HKD","LU0234570918.USD"],"gpt_icon":1},{"id":"2480887105","title":"Cervomed Inc.盘中异动 快速跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480887105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480887105?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:44","pubTimestamp":1730472241,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时44分，Cervomed Inc.股票出现异动，股价急速下跌6.15%。截至发稿，该股报12.81美元/股，成交量1.3046万股，换手率0.16%，振幅8.57%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Revolution Medicines Inc C/Wts 17/12/2026 、Ensysce Biosciences, Inc.涨幅较大，Theriva Biologics, Inc.、Gri Bio, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为3243.67%、774.77%、396.93%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Immatics N V C/Wts 01/07/2025 、Theriva Biologics, Inc.，振幅分别为122.67%、60.77%、56.84%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122440198e4008e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122440198e4008e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2478193114","title":"Cervomed Inc.盘中异动 早盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478193114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478193114?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:27","pubTimestamp":1729866446,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时27分，Cervomed Inc.股票出现异动，股价大幅上涨5.41%。截至发稿，该股报13.25美元/股，成交量7571股，换手率0.09%，振幅3.89%。Cervomed Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Elevai Labs, Inc.、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为726.08%、657.12%、159.10%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.，振幅分别为91.58%、77.79%、69.41%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222726971a259a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025222726971a259a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2477437898","title":"Cervomed Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477437898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477437898?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:02","pubTimestamp":1729526533,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时02分，Cervomed Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报13.58美元/股，成交量1.4748万股，换手率0.18%，振幅5.38%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为6794.11%、3217.91%、1398.18%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022000213ab6bc132&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022000213ab6bc132&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2473481519","title":"Cervomed Inc.盘中异动 下午盘股价大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473481519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473481519?lang=zh_cn&edition=full","pubTime":"2024-10-08 01:44","pubTimestamp":1728323053,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日01时44分，Cervomed Inc.股票出现波动，股价快速下跌5.57%。截至发稿，该股报13.55美元/股，成交量1.8937万股，换手率0.23%，振幅6.76%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1609.12%、80.48%、60.28%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为107.82%、39.46%、36.71%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080144139719eb2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080144139719eb2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2473623859","title":"Cervomed Inc.盘中异动 急速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473623859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473623859?lang=zh_cn&edition=full","pubTime":"2024-10-05 00:17","pubTimestamp":1728058626,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日00时17分，Cervomed Inc.股票出现波动，股价快速上涨5.15%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为16421.46%、64.46%、53.64%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Cue Biopharma, Inc.，振幅分别为64.43%、58.64%、52.37%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050017069719e6bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050017069719e6bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2472619024","title":"Cervomed Inc.盘中异动 早盘大幅跳水5.01%报13.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472619024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472619024?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:12","pubTimestamp":1727964741,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时12分，Cervomed Inc.股票出现波动，股价大幅下跌5.01%。截至发稿，该股报13.00美元/股，成交量1.7828万股，换手率0.22%，振幅12.11%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Elevai Labs, Inc.、Theriva Biologics, Inc.、Verrica制药涨幅较大，Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为3950.29%、990.45%、732.72%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为142.28%、47.30%、43.48%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003221222ab6799c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003221222ab6799c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2472347283","title":"Cervomed Inc.盘中异动 下午盘急速下跌5.75%报14.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472347283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472347283?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:53","pubTimestamp":1727718799,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时53分，Cervomed Inc.股票出现波动，股价急速跳水5.75%。截至发稿，该股报14.26美元/股，成交量1.5508万股，换手率0.19%，振幅4.89%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010153199719da4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010153199719da4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2470056438","title":"Cervomed Inc.盘中异动 大幅下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470056438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470056438?lang=zh_cn&edition=full","pubTime":"2024-09-28 03:41","pubTimestamp":1727466113,"startTime":"0","endTime":"0","summary":"北京时间2024年09月28日03时41分，Cervomed Inc.股票出现波动，股价急速下挫5.16%。截至发稿，该股报14.52美元/股，成交量4.5173万股，换手率0.55%，振幅7.05%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Onconetix, Inc.、Cue Biopharma, Inc.涨幅较大，Onconetix, Inc.、Seelos Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为4542.20%、289.32%、162.37%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Estrella Immunopharma, Inc.，振幅分别为167.75%、69.81%、65.94%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928034153a1dd1ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240928034153a1dd1ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2469146491","title":"Cervomed Inc.盘中异动 急速上涨5.37%报17.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469146491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469146491?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:34","pubTimestamp":1727098449,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时34分，Cervomed Inc.股票出现异动，股价快速拉升5.37%。截至发稿，该股报17.75美元/股，成交量1792股，换手率0.02%，振幅0.00%。Cervomed Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Pharmacyte  Biotech, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Black Diamond Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为54.89%、27.06%、23.30%，振幅较大的相关个股有Pharmacyte  Biotech, Inc.、天演药业、Galmed Pharmaceuticals Ltd.，振幅分别为18.52%、17.72%、16.05%。Cervomed Inc.公司简介：CervoMed Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092321341098e386e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092321341098e386e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2458254220","title":"CervoMed 公司报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458254220","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458254220?lang=zh_cn&edition=full","pubTime":"2024-08-10 05:37","pubTimestamp":1723239432,"startTime":"0","endTime":"0","summary":"   * CervoMed Inc   报告了截至1月份的季度调整后每股亏损27美分。五位分析师对该季度的平均预期是每股亏损31美分。华尔街预期为每股-44美分至-1美分。* CervoMed Inc公布的本季度每股收益为亏损27美分。* 公司季度亏损 232 万美元。* CervoMed Inc 的股价本季度下跌了 33.8%，今年迄今为止上涨了 48.6%。* 在过去 30 天内，没有覆盖该公司的分析师对盈利预期进行修正。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 CervoMed Inc 的 12 个月目标价中位数为 63.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CervoMed 公司报告截至一月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2456987632","title":"CervoMed Inc    预计每股亏损 31 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456987632","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456987632?lang=zh_cn&edition=full","pubTime":"2024-08-03 08:35","pubTimestamp":1722645339,"startTime":"0","endTime":"0","summary":"   * CervoMed Inc    预计将于8月6日公布截至2024年6月30日的财报(，预计)。* 根据LSEG的数据，4位分析师的平均估计，这家总部位于波士顿马萨诸塞州的公司预计将实现220万美元的营收。* LSEG分析师对CervoMed公司的平均预期是每股亏损31美分。* 华尔街对 CervoMed Inc 的 12 个月目标价中位数为 63.00 美元，高于其上次收盘价 10.63 美元。8月3日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CervoMed Inc    预计每股亏损 31 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRVO"],"gpt_icon":0},{"id":"2450085729","title":"CervoMed(CRVO.US)获Brookline Capital首次覆盖，给予买入评级, 目标价63.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2450085729","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450085729?lang=zh_cn&edition=full","pubTime":"2024-07-09 01:49","pubTimestamp":1720460985,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CRVO","BK4139"],"gpt_icon":0},{"id":"2439541975","title":"CervoMed(CRVO.US)获Jones Trading首次覆盖，给予买入评级, 目标价70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439541975","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439541975?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:38","pubTimestamp":1716979107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","CRVO"],"gpt_icon":0},{"id":"2439590147","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590147","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439590147?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":"    路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括欧特克、麦科森和微策略。要闻  * 模拟器件公司  ：雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc   ：贝尔德将目标价从296美元下调至289美元 * Cencora Inc   ：贝雅将目标价从277美元上调至280美元 * McKesson Corp   ：贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc   ：Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYRG","LU0310799852.SGD","CRVO","COR","ADSK","BK4130","LU1642822529.SGD","MCK","LU1978683503.SGD","PLMR","NAPA","HRT","IKNA","LU0323240290.USD","TGI","CASY","LYV","BK4214","BK4529","AKTS","ADI","RSI","SAGE","IBTX","LU0006061336.USD","BK4585","BK4139","AAL","CAVA","IE00B19Z4B17.USD","CTRE","PDFS","IE00B7SZL793.SGD","MNMD","MSTR","STZ","TKO","BK4588","BK4561","UAL","AGIO","DOMO","LU1244550221.USD","BAH","BK4528","CAH","INSM","TAP","RLJ","MNRO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cervomed.com","stockEarnings":[{"period":"1week","weight":-0.1285},{"period":"1month","weight":-0.2206},{"period":"3month","weight":-0.402},{"period":"6month","weight":-0.5467},{"period":"1year","weight":0.1041},{"period":"ytd","weight":0.4312}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CervoMed Inc.于2015年6月18日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于通过提高目前标准治疗（包括放射治疗和化疗）的有效性延长癌症患者的预期寿命。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.077022},{"month":2,"riseRate":0.625,"avgChangeRate":0.136561},{"month":3,"riseRate":0.5,"avgChangeRate":0.023523},{"month":4,"riseRate":0.375,"avgChangeRate":-0.070824},{"month":5,"riseRate":0.5,"avgChangeRate":0.190358},{"month":6,"riseRate":0.125,"avgChangeRate":-0.120544},{"month":7,"riseRate":0.125,"avgChangeRate":-0.126774},{"month":8,"riseRate":0.625,"avgChangeRate":0.065088},{"month":9,"riseRate":0.125,"avgChangeRate":-0.112535},{"month":10,"riseRate":0.125,"avgChangeRate":-0.028187},{"month":11,"riseRate":0.25,"avgChangeRate":-0.101823},{"month":12,"riseRate":0.375,"avgChangeRate":-0.133972}],"exchange":"NASDAQ","name":"CervoMed","nameEN":"CervoMed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CervoMed,CRVO,CervoMed股票,CervoMed股票老虎,CervoMed股票老虎国际,CervoMed行情,CervoMed股票行情,CervoMed股价,CervoMed股市,CervoMed股票价格,CervoMed股票交易,CervoMed股票购买,CervoMed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CervoMed(CRVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CervoMed(CRVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}